- Home
- ITIC vs RLAY Comparison
ITIC vs RLAY Comparison
Compare ITIC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- RLAY
- Stock Information
- Founded
- ITIC 1972
- RLAY 2015
- Country
- ITIC United States
- RLAY United States
- Employees
- ITIC N/A
- RLAY N/A
- Industry
- ITIC Specialty Insurers
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITIC Finance
- RLAY Health Care
- Exchange
- ITIC Nasdaq
- RLAY Nasdaq
- Market Cap
- ITIC 440.1M
- RLAY 576.1M
- IPO Year
- ITIC N/A
- RLAY 2020
- Fundamental
- Price
- ITIC $201.99
- RLAY $3.52
- Analyst Decision
- ITIC
- RLAY Strong Buy
- Analyst Count
- ITIC 0
- RLAY 11
- Target Price
- ITIC N/A
- RLAY $18.40
- AVG Volume (30 Days)
- ITIC 79.5K
- RLAY 1.5M
- Earning Date
- ITIC 08-05-2025
- RLAY 08-05-2025
- Dividend Yield
- ITIC 7.73%
- RLAY N/A
- EPS Growth
- ITIC 18.56
- RLAY N/A
- EPS
- ITIC 15.69
- RLAY N/A
- Revenue
- ITIC $261,197,999.00
- RLAY $7,679,000.00
- Revenue This Year
- ITIC N/A
- RLAY $17.59
- Revenue Next Year
- ITIC N/A
- RLAY N/A
- P/E Ratio
- ITIC $13.06
- RLAY N/A
- Revenue Growth
- ITIC 15.27
- RLAY N/A
- 52 Week Low
- ITIC $185.00
- RLAY $1.78
- 52 Week High
- ITIC $290.40
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- ITIC 44.97
- RLAY 54.94
- Support Level
- ITIC $200.78
- RLAY $3.50
- Resistance Level
- ITIC $215.27
- RLAY $3.74
- Average True Range (ATR)
- ITIC 6.06
- RLAY 0.18
- MACD
- ITIC -0.06
- RLAY -0.00
- Stochastic Oscillator
- ITIC 26.30
- RLAY 58.55
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).